S Kamihira
Overview
Explore the profile of S Kamihira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
192
Citations
1413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamihira S, Yamada Y, Maeda T
Indian J Clin Biochem
. 2012 Oct;
15(Suppl 1):101-9.
PMID: 23105273
Fas (APO-1/CD95), a transmembrane death receptor mediating apoptosis, can induce cell deathin vivo andin vitro of not only normal T-cells but also leukemic T-cells. This indicates that dysfunction in T-cell...
2.
Kamihira S, Matutes E, Marco J, Hoda S, Morilla R, Owusuankomah K, et al.
Int J Oncol
. 2011 May;
5(2):211-4.
PMID: 21559577
The relative DNA content of peripheral blood cells from 79 cases with lymphoid leukemias was analyzed by a dual-parameter flow cytometric analysis. The leukemia samples corresponded to: chronic lymphocytic leukemia...
3.
Yang H, Furukawa K, Shinzato O, Kamihira S, Moji K, Takemoto T, et al.
Int J Oncol
. 2011 May;
5(2):159-67.
PMID: 21559570
Peripheral blood mononulear cells (PBMC) derived from 10 asymptomatic human T lymphotropic virus type I (HTLV-I) carriers were cultured for a short term (10-14 days) in the absence of exogenous...
4.
Joh T, Yamada Y, Seto M, Nakamura S, Ohmoto Y, Kamihira S, et al.
Int J Oncol
. 2011 May;
9(4):619-24.
PMID: 21541560
Stromal cells isolated from lymph nodes of adult T-cell leukemia/lymphoma (ATL) patients were cultured. Such lymph node stromal cells (LNSC) could be maintained for more than one year, whereas LNSC...
5.
Hasegawa H, Yamada Y, Tsukasaki K, Mori N, Tsuruda K, Sasaki D, et al.
Leukemia
. 2011 Jan;
25(4):575-87.
PMID: 21242994
Adult T-cell leukemia/lymphoma (ATLL), an aggressive neoplasm etiologically associated with human T-lymphotropic virus type-1 (HTLV-1), is resistant to treatment. In this study, we examined the effects of a new inhibitor...
6.
Hasegawa H, Yamada Y, Iha H, Tsukasaki K, Nagai K, Atogami S, et al.
Leukemia
. 2009 Aug;
23(11):2090-101.
PMID: 19710698
It has been reported that the induction of cellular senescence through p53 activation is an effective strategy in tumor regression. Unfortunately, however, tumors including adult T-cell leukemia/lymphoma (ATL) have disadvantages...
7.
Nishimura K, Kanaoka Y, Ishiguro S, Harada S, Shiraya S, Fujiwara Y, et al.
Int Angiol
. 2009 Aug;
28(4):340-3.
PMID: 19648880
Vacuum-assisted closure (VAC) therapy is a unique system that helps promote wound healing. We report a case of severe ischemic foot in which VAC therapy markedly improved wound healing. A...
8.
Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi Y, Hasegawa H, et al.
Int J Oncol
. 2008 Sep;
33(4):697-703.
PMID: 18813782
Adult T-cell leukemia/lymphoma (ATLL) is a neoplasia characterized by the massive invasion of various organs by tumor cells. Previously, we found that expression of the gene for c-Met, a receptor...
9.
Osaka A, Hasegawa H, Tsuruda K, Inokuchi N, Yanagihara K, Yamada Y, et al.
Int J Lab Hematol
. 2008 Feb;
31(3):307-14.
PMID: 18279425
Despite the significant implication of apoptosis in tumorigenesis, there is no biomarker to assess the extent of ongoing apoptosis in vivo for hematological malignancies. We investigated the potential of serum...
10.
Niino D, Tsukasaki K, Torii K, Imanishi D, Tsuchiya T, Onimaru Y, et al.
Haematologica
. 2008 Jan;
93(1):e21-3.
PMID: 18166773
Primary effusion lymphoma (PEL) was initially designated as a body-cavity-based lymphoma and recognized as a distinct clinical entity without a contiguous tumor mass. PEL was first reported in patients with...